Daclizumab Subcutaneous and Mar-cof BP
Determining the interaction of Daclizumab Subcutaneous and Mar-cof BP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: brompheniramine / codeine / pseudoephedrine
Brand name: Mar-cof BP, M-End WC, Rydex, Mesehist WC, CPB WC
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Mar-cof CG
- Daclizumab Subcutaneous-Maraviroc
- Daclizumab Subcutaneous-Maraviroc Oral Solution
- Daclizumab Subcutaneous-Maraviroc Tablets
- Daclizumab Subcutaneous-Marcaine
- Daclizumab Subcutaneous-Marcaine HCl
- Mar-cof BP-Dacogen
- Mar-cof BP-Dacomitinib
- Mar-cof BP-Dactinomycin
- Mar-cof BP-Dactinomycin Injection
- Mar-cof BP-Dactinomycin Intravenous
- Mar-cof BP-Daklinza